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Abstract 
The airways of cystic fibrosis patients colonised by Pseudomonas aeruginosa contain the redox active phenazine derivative, 
I-hydroxyphenazine (OHP). As the presence of reactive oxygen species is of importance to tissue damage in cystic fibrosis, OHP was 
investigated for its ability to reduce molecular oxygen to superoxide. In the presence of NADPH, OHP reduced cytochrome c in a 
dose-dependent manner. This effect was not inhibited by superoxide dismutase and demonstrates an electron transport role for OHP. The 
OHP/NADPH system was unable to reduce molecular oxygen to superoxide as judged by an inability to oxidase epinephrine to 
adrenochrome. However, using lucigenin-enhanced chemiluminescence to detect superoxide, it was found that pathophysiologically 
relevant concentrations of OHP (5-25 FM) effectively scavenged superoxide from a xanthine/xanthine oxidase system. Similarly, in the 
presence of OHP, superoxide availability from contact-activated neutrophils was substantially reduced. It is concluded that OHP is an 
efficient scavenger of superoxide and that electron transfer from superoxide to OHP represents a major mechanism for reduction of OHP 
in vivo. Reduced OHP has the potential to alter cellular function by participating in the reduction of iron-containing proteins and in this 
manner contribute to the pathogenesis of P. aeruginosa infection in cystic fibrosis. 
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1. Introduction 
Cystic fibrosis is the most common lethal genetic disor- 
der afflicting people of Caucasian origin, with an incidence 
of approximately I:2000 live births [I]. Progressive de- 
struction of the airways of patients with cystic fibrosis is 
associated with an influx of neutrophils in response to 
colonisation of the airways by Pseudomonas aeruginosa 
121. Tissue destruction is attributed to neutrophil-derived 
proteases, reactive oxygen species and the myeloperoxi- 
dase reaction [3]. P. aeruginosa produces a number of 
well characterised virulence factors including phospho- 
lipase C [4], proteases [51 and exotoxin A [6]. Less well 
characterised are the phenazine derivatives produced by 
the organism. One of these derivatives, l-hydroxyphena- 
zine (OHP, Fig. I), has been isolated from the sputum of 
Abbreviations: OHP, I-hydroxyphenazine; SOD, superoxide dismu- 
tase; XXO, xanthine/xanthine oxidase. 
* Corresponding author. Fax + 6 1 2 891 53 17. 
0925.4439/95/$09.50 0 1995 Elsevier Science B.V. All rights reserved 
SSDlO925-4439(95)00086-O 
cystic fibrosis patients [7]. OHP has been implicated as an 
inhibitor of lymphocyte proliferation [8,9], while other 
studies have found that OHP stimulates the release of 
granule contents from activated neutrophils including 
myeloperoxidase [lo] and elastase [l 11. Previously, this 
laboratory has identified OHP as an inhibitor of human 
neutrophil 5lipoxygenase activity [ 121. The mechanisms 
by which OHP produces its biological effects are not 
known; however, in the case of lipoxygenase inhibition the 
redox activity of OHP may be responsible. Lipoxygenases 
undergo reversible reductive inactivation by redox active 
compounds [ 13,141. Alternatively, some phenazine deriva- 
tives can generate reactive oxygen species [ 151 which 
irreversibly inactivate lipoxygenase enzymes [ 161. 
While the redox nature of OHP has been described [ 171, 
its role as an electron carrier or in the generation of 
reactive oxygen species has not been addressed. Similarly, 
the mechanisms by which OHP may be reduced by cellular 
systems are uncertain. Armstrong et al. reported that OHP 
blocks mouse-liver mitochondrial electron transport and 
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Fig. I. Structure of I-hydroxyphenaaine. 
speculated that OHP may act as an electron acceptor [ 181. 
Other studies have shown that OHP is reduced by NADPH 
though the rate of reduction within the physiological pH 
range is slow [ 191. 
This study was undertaken to determine if OHP partici- 
pates in electron transfer reactions with molecular oxygen 
or its reduced derivative, superoxide. While it was found 
that OHP is unable to reduce molecular oxygen to superox- 
ide, OHP was found to be an efficient scavenger of 
superoxide produced by cell-free and cellular systems. It 
was further demonstrated that OHP mediates the reduction 
of cytochrome c. These results suggest that superoxide 
production by activated phagocytes provides a means for 
the in vivo reduction of OHP. Reduced in this manner, 
OHP has the potential to alter cellular functions by partici- 
pating in the reduction of iron-containing proteins. 
2. Materials and methods 
2. I. Reagents 
All reagents were purchased from Sigma unless other- 
wise stated. Reagents were prepared just prior to use in 
Hanks’ balanced salts solution containing calcium and 
magnesium without phenol red (HBSS, pH 7.4) and pro- 
tected from light. 
2.2. Synthesis of OHP 
OHP was prepared by alkaline treatment of pyocyanin 
by modification of the method of Gessard [20]. Briefly, 
pyocyanin was dissolved in a 1% solution of sodium 
hydroxide and allowed to stand in the dark for 3 h. The 
solution was acidified with 1 M HCl until a yellow precipi- 
tate was obtained. The crude OHP was extracted twice into 
one volume of chloroform and the pooled extracts were 
evaporated to dryness under vacuum. OHP was reconsti- 
tuted in methanol and purified by thin-layer chromatog- 
raphy on silica gel G. The developing solvent consisted of 
chloroforn-nmethanol (9:l v/v>. The band containing the 
purified yellow OHP was removed and eluted twice with 
methanol, dried and stored in methanol at -70°C. Py- 
ocyanin was prepared as described previously [ 191. The 
purity of the OHP was assessed by comparison of its 
spectral characteristics and extinction coefficients with es- 
tablished values [21]. 
2.3. Neutrophil preparation 
Neutrophils were prepared from the whole blood of 
consenting, healthy volunteers. Briefly, 1 volume of 6% 
dextran T-500 (Pharmacia) was added to 9 ~01s. of whole 
acid/citrate/dextrose anticoagulated blood and the 
erythrocytes allowed to sediment under gravity for 20 min. 
The upper neutrophil-rich layer was removed and cells 
pelleted by centrifugation at 250 X g for 10 min. The 
neutrophils were further purified by centrifugation for 30 
min at 250 X g on Ficoll-Paque (Pharmacia). The lower 
pellet was collected and contaminating erythrocytes re- 
moved by hypotonic lysis. Neutrophils were washed and 
suspended at 1 X 10” cells/ml in HBSS before use. A 
total volume of 100 ~1 of neutrophil suspension was used 
for each experiment. Neutrophil purity was greater than 
95% as determined by a STKS Coulter counter and viabil- 
ity was greater than 98% as determined by Trypan blue 
dye staining. 
2.4. Cytochrome c reduction assay 
Cytochrome c reduction was measured in the presence 
of OHP (O-50 PM) and NADPH (100 ~Mur) or xanthine 
(100 PM) and xanthine oxidase (7.7 mu/ml). The units 
of xanthine oxidase activity were as defined by the sup- 
plier (Sigma). Reduction of the cytochrome (40 PM) was 
monitored at 550 nm at 22°C against a reference blank 
containing HBSS. For appropriate experiments, results were 
compared to equivalent samples to which superoxide dis- 
mutase (SOD, 30 U/ml) had been added and the SOD-in- 
hibitable fraction determined. For anaerobic experiments 
cuvettes containing reactants minus the starting component 
(NADPH or xanthine) were de-oxygenated by the passage 
of a gentle stream of high purity nitrogen for 20 min 
through the solution. The reaction was started by the 
addition of the starting component in 10 ~1 HBSS and 
absorbance measured for 15 min. Oxygen was excluded 
during the course of the reaction. An extinction coefficient 
of 29.5 mmol litre-’ cm- ’ (provided by the supplier) was 
used to calculate the amount of cytochrome reduced. 
2.5. Epinephrine oxidation assay 
Oxidation of epinephrine was used as an independent 
test for the presence of superoxide [22]. The rate of 
oxidation of epinephrine (5 mM) to adrenochrome was 
monitored by measuring the absorbance at 480 nm over 15 
min at 22°C in the presence of OHP (O-50 PM) and 
NADPH (100 PM). Each sample was read against a 
reference blank containing HBSS. 
2.6. Chemiluminescence assay 
All chemiluminescence experiments were performed us- 
ing a Canberra Packard Tri-Carb 4000 series liquid scintil- 
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lation counter in non-coincidence mode at 32°C. Assays 
were performed in PolySorp microtitre wells (Nunc) which 
contained a total volume of 100 ~1. These wells have 
specific surface characteristics which, in the absence of 
other stimuli, provide reproducible contact activation of 
neutrohils for superoxide production. Lucigenin (his-N- 
methylacridinium nitrate) was used as the lumigenic com- 
pound as it has greater specificity for superoxide than 
luminol (5amino-2,3-dihydro- 1,4-phthalazinedione) and 
does not react with products of the myeloperoxidase reac- 
tion [23,24]. Unlike luminol, lucigenin does not cross 
cellular membranes and so provides a better assessment of 
extracellular superoxide production [25]. In all chemilumi- 
nescence experiments lucigenin was used at a concentra- 
tion of 1.50 PM. Due to possible quenching effects on the 
emission of light, no organic solvents were used in the 
preparation of reagents. Each sample was monitored for 20 
min with a 30-s signal acquisition time. 
3. Results 
3.1. Reduction of cytochrome c by OHP/NADPH 
In the presence of NADPH, OHP (5-50 PM) caused a 
dose-dependent reduction of cytochrome c (Fig. 2). 
NADPH or OHP alone failed to reduce the cytochrome. 
There was no difference in the rate of reduction of cy- 
tochrome c by OHP/NADPH when the experiments were 
performed in the presence of SOD (30 U/ml) or under 
anaerobic conditions (data not shown). 
3.2. E#ect of OHP on reduction qf cytochrome c by 
xanthine /xanthine oxidase 
In the presence of OHP (25 PM) the rate of cytochrome 
c reduction by a xanthine/xanthine oxidase (Xx0) system 
4r 
Time (min) 
Fig. 2. Reduction of cytochrome c by OHP. Cytochrome c (40 FM) was 
incubated with NADPH (100 PM) and OHP (O-50 /*M) and the 
absorbance was monitored for 15 min at 550 nm. Results represent the 
mean+ S.D. of three separate experiments: each experiment was per- 
formed in triplicate. 
Time (min) 
Fig. 3. Effect of superoxide dismutase and nitrogen on cytochrome ( 
reduction in the presence of OHP. The reduction of cytochrome c (40 
KM) in the presence of xanthine (100 FM) and xanthine oxidase (7.7 
mu/ml) was monitored for 15 min at 550 nm. Under anaerobic condi- 
tions or under aerobic conditions with superoxide dismutase (SOD. 30 
U/ml) reduction of the cytochrome did not occur in the presence or 
absence of OHP (25 FM). Results represent the mean of three separate 
experiments: each experiment was performed in triplicate, 
was not significantly altered (Fig. 3). Further experiments 
demonstrated that under anaerobic conditions OHP (25 
PM) and XX0 failed to reduce cytochrome c. Under 
aerobic conditions and in the presence of SOD (30 U/ml). 
with or without OHP, cytochrome c reduction was sub- 
stantially eliminated demonstrating the essential role of 
superoxide for the reduction of the cytochrome. These 
results are summarised in Fig. 3 and demonstrate that OHP 
is not reduced directly by XXO. 
3.3. Oxidation of epinephrine 
Oxidation of epinephrine to adrenochrome provides a 
sensitive means of detecting superoxide; however, under 
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Fig. 4. Effect of OHP on superoxide availability from a cell free 
generating system. Superoxide, generated by xanthine (100 PM) and 
xanthine oxidase (7.7 mU/ml), was monitored for 15 min in the presence 
of OHP (O-25 PM) and lucigenin (I 50 PM). Results represent the mean 
of three separate experiments; each experiment was performed in tripli- 
cate. 
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Fig. 5. Effect of OHP on neutrophil-derived superoxide availability. 
Contact activated neutrophils (5 X 10’ cell/ml) were monitored for su- 
peroxide production in the presence of OHP (O-50 PM) and lucigenin 
(150 PM) for 15 min. Results represent the mean of three separate 
experiments; each experiment was performed in triplicate. 
the conditions described superoxide production was not 
detected from the reaction of OHP (O-50 PM) with 
NADPH (100 PM) (data not shown). 
3.4. Inhibition of xanthine/xanthine oxidase-dependent 
chemiluminescence by OHP 
Prior to commencing the chemiluminescence experi- 
ments OHP was tested to ensure that it did not interfere 
with the production or transmission of light from the 
lucigenin reaction. A standard amount of hydrogen perox- 
ide (0.03% in HBSS) was added to a microtitre well 
containing lucigenin (150 PM) in a total volume of 100 
~1. Having established the rate of chemiluminescence due 
to hydrogen peroxide over 20 min, the experiment was 
repeated with varying concentrations of OHP. No signifi- 
cant difference in chemiluminescence due to the presence 
of OHP was found (data not shown). The presence of 
superoxide as determined by lucigenin in the XX0 system 
was reduced in a dose-dependent manner by OHP (Fig. 4). 
At a concentration of 12.5 PM, OHP achieved 86.1% 
inhibition of the maximal response (at 6 min) and 86.2% 
inhibition of the total response over 20 min. 
3.5. Scavenging of neutrophil superoxide by OHP 
As in the XX0 experiments, a dose-dependent inhibi- 
tion of superoxide production by contact-activated neu- 
Xanthine 
Oxidase 
OHP 
I 
Cytochrome c 
Fig. 6. Aitemative pathways for cytochrome c reduction in the presence 
of OHP. 
trophils was observed in the presence of OHP (Fig. 5). 
However, the extent of inhibition was less with the neu- 
trophils than with the XX0 system. OHP (12.5 PM) 
reduced superoxide availability for both maximal (67.0% 
inhibition at 7 min) and total chemiluminescence (63.6% 
inhibition) over 20 min compared to the control. 
4. Discussion 
This study has demonstrated that reduced OHP can 
mediate the reduction of the iron-containing protein, cy- 
tochrome c, but not molecular oxygen. Using lucigenin-en- 
hanced chemiluminescence, it was found that OHP is an 
efficient dose-dependent scavenger of superoxide under 
cell-free and cellular conditions and at concentrations that 
are pathophysiologically relevant [7]. However, it has been 
reported previously by Ras et al. that OHP does not 
scavenge superoxide [lo]. These authors assessed superox- 
ide production in the presence of OHP from a hypoxan- 
thine/xanthine oxidase system and from activated neu- 
trophils using the SOD-inhibitable fraction of cytochrome 
c reduction. As demonstrated in this study, OHP can 
transfer electrons directly to cytochrome c. Thus, scaveng- 
ing of superoxide by OHP would not be apparent using the 
SOD-inhibitable fraction of the cytochrome c reduction 
assay as both the cytochrome and OHP can compete for 
electrons from superoxide. The proposed mechanism to 
account for these results is illustrated in Fig. 6. When 
cytochrome c is replaced by lucigenin, with which reduced 
OHP does not react, the scavenging effect of OHP be- 
comes apparent. The greater potency of OHP for inhibition 
of the cell-free system in comparison to the neutrophil 
system is possibly due to the lipophilic nature of OHP. 
Partitioning of OHP into the lipid membrane of the neu- 
trophils would make it unavailable for interaction with 
superoxide as the latter cannot partition into the mem- 
brane. Under in vivo conditions scavenging of superoxide 
by OHP may be similarly limited due to its penetration of 
cellular structures. 
The presence of OHP at sites of infection may con- 
tribute to the survival of P. aeruginosa within the host. 
The effectiveness of the phagocytic host defence system 
relies, in part, on the ability to generate superoxide by the 
NADPH oxidase complex. While superoxide is not very 
reactive towards bio-molecules, it is the precursor of more 
reactive agents, including hydrogen peroxide and the 
myeloperoxidase product, hypochlorous acid, both of which 
are potent microbicidal agents [26]. P. aeruginosa pro- 
duces a number of extracellular products which diminish 
the effects of reactive oxygen species. Thus the production 
of pyocyanin by the organism inhibits the NADPH oxidase 
activity of phagocytic cells by diminishing cellular levels 
of NADPH [27]. In addition, isolates of P. aeruginosa 
from cystic fibrosis patients exhibit a mucoid phenotype 
due to the production of alginate. Alginate has been found 
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to be an effective scavenger of phagocyte-derived free 
radicals [28]. Thus the presence of OHP within the local 
environment of the bacterium may augment the protective 
role of pyocyanin and alginate against phagocyte-derived 
radical species. Studies with other organisms have demon- 
strated the importance of superoxide scavengers, such as 
melanin. in providing both in vitro and in vivo protection 
against the effects of reactive oxygen species [29,30]. 
Therefore the presence of OHP in the airways of patients 
with chronic P. aeruginasa infection may contribute to the 
persistence of the organism. 
While this study has demonstrated that the redox prop- 
erties of OHP do not contribute to the generation of 
reactive oxygen species. of interest in the finding that 
activated phagocytes provide suitable conditions for OHP 
reduction. Miiller et al. have demonstrated that reduced 
phenazine derivatives can cross cellular membranes [27]. 
Thus the intracellular presence of reduced OHP may pro- 
duce altered cellular responses due to changes in the redox 
state of cellular components. The ability of OHP to inhibit 
neutrophil 5-lipoxygenase activity [ 121 but not platelet 
12-lipoxygenase activity (unpublished data) may be related 
to the inability of platelets to produce superoxide or to 
effectively reduce OHP by other means. Compounds such 
as OHP may therefore serve as a 
design of novel anti-inflammatory 
activated by superoxide, modulate 
responses. 
useful model for the 
agents which, when 
cellular lipoxygenase 
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